Skip to main content

Table 1 Dose objectives for traditional dose optimization on HT and TD

From: Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations

Structure

Parameter

Objective

PTV

Dmean(Gy)

30

 

V90% (%)

99

 

V95% (%)

95

 

V107% (%)

1

Breast

V4Gy (%)

50

 

V10Gy (%)

33

Lung

V5Gy (%)

50

 

V10Gy (%)

33

Thyroid

V18Gy (%)

50

 

V25Gy (%)

33

Heart

V7.7Gy (%)

50

 

V15Gy (%)

33

Coronary Ostia

V20Gy (%)

100